companydata.dkcompanydata.dk

LEKAPHARM A/S: Financial statements 2019

CVR: 32945945

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

LEKAPHARM A/S (CVR 32945945) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 3,272,989 and a net result of DKK 633,133 compared with DKK 1,138,029 the year before. That is a decrease of 16.4% compared with the year before. Equity in the 2019 report amounted to DKK 10,021,611. The solvency ratio was 56%. The company had 3 employees in the financial year.

Gross Profit
DKK 3,272,989
Profit/Loss
DKK 633,133
Equity
DKK 10,021,611
Total Assets
DKK 17,890,219
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-3.3 mio.633 t.10 mio.3
2018-3.9 mio.1.1 mio.10.4 mio.3
2017-5.5 mio.2.5 mio.10.3 mio.4
2016-6.7 mio.3.2 mio.10.3 mio.5
2015-5.3 mio.1.9 mio.8.7 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

LEKAPHARM A/S: The 2018 annual report is outJun 19, 2019

LEKAPHARM A/S has published its annual report for 2018. Gross profit came to DKK 3,915,671, and the net result was DKK 1,138,029.

About LEKAPHARM A/S

LEKAPHARM A/S is a Danish company of the type Aktieselskab based in Kværndrup, founded in 2010. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Lasse Kjeldsen. The board consists of Susanne Frederiksen (chair), Emil Bødker Kjeldsen and Lasse Kjeldsen. The company is owned by LKJ HOLDING 2010 ApS, CE-PHARMAMACHINERY ApS and Familien Kjeldsen Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 10,369,416 and a net result of DKK 5,517,066 compared with DKK 2,051,529 the year before. Equity in the 2025 report amounted to DKK 7,972,163.

Source: annual report 2025, Danish Business Authority